These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25038581)

  • 1. Tumoral reprogramming: Plasticity takes a walk on the wild side.
    Campos-Sánchez E; Cobaleda C
    Biochim Biophys Acta; 2015 Apr; 1849(4):436-47. PubMed ID: 25038581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological cellular reprogramming and cancer.
    Abollo-Jiménez F; Jiménez R; Cobaleda C
    Semin Cancer Biol; 2010 Apr; 20(2):98-106. PubMed ID: 20188173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress as a fundamental theme in cell plasticity.
    Shoshani O; Zipori D
    Biochim Biophys Acta; 2015 Apr; 1849(4):371-7. PubMed ID: 25038585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency.
    Ferreirós A; Pedrosa P; Da Silva-Álvarez S; Triana-Martínez F; Vilas JM; Picallos-Rabina P; González P; Gómez M; Li H; García-Caballero T; González-Barcia M; Vidal A; Collado M
    Stem Cell Reports; 2019 May; 12(5):1099-1112. PubMed ID: 31056476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress induces cell dedifferentiation in plants.
    Grafi G; Barak S
    Biochim Biophys Acta; 2015 Apr; 1849(4):378-84. PubMed ID: 25086338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
    Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J
    Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 connects tumorigenesis and reprogramming to pluripotency.
    Tapia N; Schöler HR
    J Exp Med; 2010 Sep; 207(10):2045-8. PubMed ID: 20876313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular reprogramming and cancer development.
    Semi K; Matsuda Y; Ohnishi K; Yamada Y
    Int J Cancer; 2013 Mar; 132(6):1240-8. PubMed ID: 23180619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: dedifferentiation meets cancer development: proof of concept for epigenetic cancer.
    Yamada Y; Haga H; Yamada Y
    Stem Cells Transl Med; 2014 Oct; 3(10):1182-7. PubMed ID: 25122691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo.
    Ohnishi K; Semi K; Yamada Y
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular barriers to processes of genetic reprogramming and cell transformation.
    Chestkov IV; Khomyakova EA; Vasilieva EA; Lagarkova MA; Kiselev SL
    Biochemistry (Mosc); 2014 Dec; 79(12):1297-307. PubMed ID: 25716723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application.
    Yamada Y; Yamada Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(6):235-247. PubMed ID: 29887568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cellular plasticity in cancer development.
    Vicente-Dueñas C; Gutiérrez de Diego J; Rodríguez FD; Jiménez R; Cobaleda C
    Curr Med Chem; 2009; 16(28):3676-85. PubMed ID: 19747147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and stem cells: new developments and new concerns.
    Zhao T; Xu Y
    Trends Cell Biol; 2010 Mar; 20(3):170-5. PubMed ID: 20061153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedifferentiation and the role of sall4 in reprogramming and patterning during amphibian limb regeneration.
    Neff AW; King MW; Mescher AL
    Dev Dyn; 2011 May; 240(5):979-89. PubMed ID: 21305648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The netrin-1 cue regulates somatic cell reprogramming to pluripotency].
    Mehlen P; Lavial F
    Med Sci (Paris); 2016 Mar; 32(3):241-4. PubMed ID: 27011240
    [No Abstract]   [Full Text] [Related]  

  • 20. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.